DCLK3 and melanoma: To depict the potential modulation of the CLR profile in the context of melanoma especially in the tumor microenvironment, we compared blood of patients (Pt) with healthy donors (HD), and tumor tissue with control tissue because the CLR profile of DCs in control (HD) conditions differed in blood and tissue.